Guardian Pharmacy Services, Inc. (GRDN) stock is soaring 6.86% in early trading on Tuesday, as investors react positively to the company's recently released third-quarter earnings report. The healthcare company's shares are seeing significant upward momentum, reflecting growing investor confidence in its financial performance and future prospects.

The surge in Guardian Pharmacy Services' stock price comes on the heels of its Q3 earnings release, which showcased impressive financial results. While specific figures were not provided, the company reported a boost in revenue and, more importantly, raised its guidance for the upcoming periods. This upward revision in financial outlook suggests that Guardian Pharmacy Services' management is confident in the company's growth trajectory and ability to deliver strong results in the future.

Adding to the positive sentiment, analysts have weighed in on Guardian Pharmacy Services following the earnings announcement. Notably, Stephens has raised its target price for GRDN from $28 to $32, indicating increased optimism about the company's valuation. This vote of confidence from Wall Street, coupled with the strong earnings report, appears to be driving the significant uptick in Guardian Pharmacy Services' stock price during today's trading session.